Chi Zhang

Chi Zhang is a seasoned professional in the field of research and development, currently serving as Vice President at Iris Medicine since April 2023, previously holding the position of Senior Director of Nonclinical Development at the same company. Prior experience includes a role as Director of Molecular & Cellular Pharmacology at Encoded Therapeutics Inc., where Chi Zhang worked on preclinical biology related to CNS and liver diseases, as well as gene therapy. Chi Zhang's career includes significant contributions as a Scientist at Encoded Therapeutics Inc., a Research Fellow at Harvard Medical School, and a Consultant at Sage Therapeutics. Academic credentials include a PhD in Biology from Harvard University and a BS in Biological Sciences from Tsinghua University. Leadership experience encompasses serving as Co-President of the Chinese Biomedical Student Organization, managing funding and board recruitment efforts.